Soligenix Inc. (SNGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.50M
Last updated: Nov 17, 2026 at 11:02 AM ET
Soligenix Inc. (SNGX) Competitors
The companies most similar to Soligenix are Ensysce Biosciences (ENSC), Exicure (XCUR) and In8bio (INAB). By market cap, Soligenix ranks 7th of the 13 companies on this page; Vyome Holdings (HIND) is the largest at $11.09M.
Peer Comparison
SNGX's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Soligenix (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Ensysce Biosciences Inc (ENSC) | $8.14M | N/A | 1.2x | -280.5% | -260.6% | -15.1% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| In8bio Inc (INAB) | $8.86M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| VistaGen Therapeutics Inc (VTGN) | $8.01M | N/A | 3.4x | 0.0% | N/A | -46.5% | 0.00% |
| Galmed Pharmaceuticals Ltd (GLMD) | $4.95M | N/A | N/A | 0.0% | N/A | 0.0% | N/A |
| Vyome Holdings, Inc. (HIND) | $11.09M | N/A | N/A | 0.0% | N/A | 67.5% | 0.00% |
| Evogene (EVGN) | $6.70M | N/A | 3.7x | 0.0% | N/A | -60.7% | 0.00% |
| Moleculin Biotech Inc (MBRX) | $8.02M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| GT Biopharma Inc (GTBP) | $7.67M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Processa Pharmaceuticals Inc (PCSA) | $5.20M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Peer median | $7.37M | N/A | 3.5x | 0.0% | -131.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Soligenix, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Ensysce Biosciences Inc (ENSC) | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. | ENSC competitors |
| Exicure Inc (XCUR) | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
| In8bio Inc (INAB) | IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers... | INAB competitors |
| Senti Biosciences Inc (SNTI) | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| VistaGen Therapeutics Inc (VTGN) | VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential... | VTGN competitors |
| Galmed Pharmaceuticals Ltd (GLMD) | Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. | |
| Vyome Holdings, Inc. (HIND) | Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States... | HIND competitors |
| Evogene (EVGN) | Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel. | EVGN competitors |
| Moleculin Biotech Inc (MBRX) | Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant... | MBRX competitors |
| GT Biopharma Inc (GTBP) | GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its... | GTBP competitors |
| Processa Pharmaceuticals Inc (PCSA) | Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients... | PCSA competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
Frequently Asked Questions About SNGX
Who are Soligenix's main competitors?
The companies most similar to Soligenix include Ensysce Biosciences (ENSC), Exicure (XCUR), In8bio (INAB), Senti Biosciences (SNTI) and VistaGen Therapeutics (VTGN), listed from the closest match.
Who is Soligenix's biggest competitor?
Vyome Holdings (HIND) is the largest of the similar companies at $11.09M; Ensysce Biosciences (ENSC) is the closest match by business profile, size, sector and industry.
How does SNGX stock compare with its competitors?
SNGX's net margin is 0.0% against a peer median of 0.0%.
Which of Soligenix's competitors pays a higher dividend?
Soligenix pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Soligenix bigger than its competitors?
No. Soligenix is 7th by market cap among the 13 companies on this page; the largest is Vyome Holdings (HIND) at $11.09M.
SNGX pages: Overview, Earnings, Forecast, Financials, Competitors